PLOS Medicine

The PLOS flagship journal in medicine and public health related fields.

[PLOS Medicine @PLOSMedicine]

PLOS is no longer posting on this platform. We remain fully committed to promoting PLOS Medicine and its content and will continue to amplify our research and connect with key audiences and communities across other social media platforms.

[PLOS Medicine @PLOSMedicine]

This will include via our PLOS LinkedIn account (https://t.co/pKkarl2IZP) and our PLOS BlueSky account (https://t.co/di1n9eXgae).

[PLOS Medicine @PLOSMedicine]

PLOS is no longer posting on this platform. We remain fully committed to promoting PLOS Medicine and its content and will continue to amplify our research and connect with key audiences and communities across other social media platforms.

[PLOS Medicine @PLOSMedicine]

Who are the children most vulnerable to malaria?
In this Policy Forum, Raquel González and colleagues discuss the drugs available to HIV-exposed children to prevent malaria infection and the urgent need to evaluate alternative agents.
🔎: https://t.co/0WylXTfVCk

[Int Society of Nephrology @ISNkidneycare]

Results from ISN’s Kidney Care Network published in @PLOSMedicine: "Advancing Acute Kidney Disease Management in Low-resource Settings." Read more: https://t.co/ANPfmw6luv

[PLOS Medicine @PLOSMedicine]

Yuqi Hu, Le Gao and team compare the incidence of haematological malignancies between clozapine and olanzapine users using electronic health records from Hong Kong public health facilities.
@FranciscoTTLai1 @legao0513 @YuqiHu_
@Yi_Chai18 @HkuPharm @HKUMed
https://t.co/i89QKfIAJq

[PLOS Medicine @PLOSMedicine]

Rhys Evans and team evaluate the performance of a risk score to aid acute kidney disease identification and determine kidney and patient outcomes of AKD in Bolivia, Brazil, Nepal, and South Africa.
@rhysdrevans @RenalUCL
@RClaure_nefro @ISNkidneycare
📊: https://t.co/Uk0vP4dr49

[PLOS Medicine @PLOSMedicine]

Frederick Ho, Caroline Dale and colleagues explore how routine measurements of cardiometabolic risk factors have changed over the course of the pandemic and in the recovery phase.
@fredho42 @UofGSHW
📎: https://t.co/3rrggKTcAh

[PLOS Medicine @PLOSMedicine]

Laura A. Magee and colleagues evaluate the optimal timing of birth for women with chronic or gestational hypertension at term, in a multi-centre open-label randomised trial.
@LauraAMagee1 @Pvondadelszen
📄: https://t.co/T8kHnhOokF

[PLOS Medicine @PLOSMedicine]

Carey Gleason, N. Maritza Dowling, Firat Kara and team explore the long-term effects of hormone therapy started early in menopause on cognition, mood and neuroimaging using data from the Kronos Early Estrogen Prevention Study (KEEPS) cohort.
@GleasonCarey
https://t.co/YmsW512zPr

[PLOS Medicine @PLOSMedicine]

Amanda Paust and team leverage data from the 2017 Danish National Health Survey to explore how economic, cultural, and social inequalities contribute to inappropriate medication prescribing.
@AmandaPaust @AndersPriority @AarhusUni
📄: https://t.co/jKbvoV6HFF

[PLOS Medicine @PLOSMedicine]

Erikka Loftfield and team discuss that while consumption of ultra-processed foods has increased worldwide, associations with cancer risk remain unclear and underlying mechanisms speculative. Time for a robust, multidisciplinary research agenda?
📎: https://t.co/Nc08V48kzx

[PLOS Medicine @PLOSMedicine]

Jean Adams discusses whether the NOVA system and the UPF concept, by drawing on both life and social science paradigms, can address not only the problem of harmful foods, but also harmful food systems.
📝: https://t.co/00St0mQ5zj

[Mayo Clinic @MayoClinic]

Mayo Clinic researchers found short-term hormone therapy for menopause symptoms did not lead to long-term cognitive impairment among women with good cardiovascular health in a new paper published in @PLOSMedicine.

Learn more: https://t.co/9KCN70mDPC

[PLOS Medicine @PLOSMedicine]

Rongtao Lai and team estimate hepatocellular carcinoma incidence stratified by a combination of age, sex, cirrhosis, diabetes, and other comorbidities as derived from data of ~750,000 real-world patients with steatotic liver disease.
@NguyenLab_SU
📎: https://t.co/v1vbCKQpkw

[PLOS Medicine @PLOSMedicine]

Michael R. Whitehouse, Rita Patel and colleagues investigate the revision rate of primary total hip replacement reported in the National Joint Registry by specific types of bearing surfaces used.
@LenguerrandErik
@Wheres_elsa
📊: https://t.co/pj71wwN2fq

[Professor Nicola Heslehurst 💙 (she/her) @NHeslehurst]

New paper alert! Meta-analysis shows food insecure pregnant women have up to 4x odds of poor mental health, increased GDM & dental health problems.
@fuse_online
@Lakenutrition @StephanieO18 @GinaGiang @ZoBell20 @UniofNewcastle @nourishingftrs @PLOSMedicine https://t.co/g8tR99PC9d

[PLOS Medicine @PLOSMedicine]

Leveraging registry data, Peter Jepsen and colleagues explore the risk of adverse health outcomes among offspring and associations with diagnosis of alcohol-related liver disease of one or both parents and parents' education level.
📄: https://t.co/RxA88VwxyM

[PLOS Medicine @PLOSMedicine]

Peter MacPherson and colleagues analyze public health records and demographics data using an interrupted time series approach to explore the effect of the 1957 Glasgow mass chest X-ray campaign for tuberculosis case finding.
@UofGSHW
📎: https://t.co/SF41MGKPYx

[Tom Wingfield @DrTomWingfield]

Stellar work by @petermacp and colleagues!! As ever in the field of tuberculosis, be it social protection or chest radiographic imaging, we can learn so much from past strategies that informs our future advances....
@PLOSMedicine https://t.co/u4TalFy72N
& https://t.co/pdYQgmhRB9

[PLOS Medicine @PLOSMedicine]

Bouke C. de Jong and team assess the safety of bedaquiline combined with rifampicin for leprosy post-exposure prophylaxis in the Comoros Islands.
@ITMAntwerp
@NimerOrtuno
@ChrisvanderWerf
🔎: https://t.co/DQXBUXcAts